Venture Capital

With only 5% of game developers being Black, Spelman's HBCU Game Jam is building a vital pipeline for new creators to change the industry from within.

Lucid's upcoming Investor Day will reveal its plan for profitability, centered on a groundbreaking Uber robotaxi partnership and a new, affordable EV line.

BETA Technologies will launch electric air services across 10 states, deploying its ALIA aircraft for cargo, medical, and critical logistics missions.

A booming multi-trillion-dollar market may be harboring systemic risks that traditional models miss. New research warns of a potential liquidity crisis.

A new 'high-signal' AI summit in San Francisco plans to unite 2,000 leaders, bridging frontier research and enterprise ahead of GTC's tech-week frenzy.

Neros Technologies delivers early on a key U.S. Army drone program and launches its next-gen, field-reconfigurable FPV system for modern warfighters.

Killer Mike, T.I., and legal experts urge the Supreme Court to end the use of rap lyrics as evidence, arguing it stokes racial bias in capital cases.

Ottawa injects over $900M into defence innovation, fueling a new strategy to boost domestic tech, meet NATO commitments, and create high-skill jobs.

A North Carolina startup claims a massive efficiency leap in Direct Air Capture, putting the sub-$100/ton 'holy grail' of carbon removal within reach.

EGI Battery is opening a new NDAA-compliant facility in Michigan to produce advanced batteries for drones, aerospace, and robotics, bolstering U.S. tech autonomy.

With the appointment of Expedia alum Dhiren Fonseca as Executive Chairman, Rent the Runway signals a strategic shift towards scaling and profitability.

Fintech KAST lands $80M from QED and Left Lane to build a global bank on stablecoin rails, targeting a major shift in how the world moves money.

With $25M in total funding, a Cambridge startup is building AI that obeys the laws of physics, aiming to eliminate hallucinations in critical engineering.

With 8x sales growth and 90% prediction accuracy, AI pioneer QuantHealth is proving that simulating clinical trials can slash pharma's $50B failure rate.

NOAA's approval of a key application for seabed mining boosts US critical mineral hopes but sparks fierce opposition from scientists and nations fearing ruin.

With defense spending hitting $2.6T, a new arms race in Edge AI is on. Discover how specialized tech is enabling autonomous warfare and reshaping conflict.

A new, highly selective drug for Duchenne muscular dystrophy shows potential to be safer and more effective, targeting both muscle and heart decline.

A $5M US government investment in a Macedonian antimony mine aims to secure Western supply chains, de-risking a potential IPO for Australia's Pela Global.

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

A new drug, CRS3123, not only cures C. difficile but drastically cuts recurrence rates by preserving the gut microbiome, a major leap over standard care.